Vrinceanu, N.; Hlihor, R.M.; Simion, A.I.; Rusu, L.; Fekete-Kertész, I.; Barka, N.; Favier, L.
New Evidence of the Enhanced Elimination of a Persistent Drug Used as a Lipid Absorption Inhibitor by Advanced Oxidation with UV-A and Nanosized Catalysts. Catalysts 2019, 9, 761.
https://doi.org/10.3390/catal9090761
AMA Style
Vrinceanu N, Hlihor RM, Simion AI, Rusu L, Fekete-Kertész I, Barka N, Favier L.
New Evidence of the Enhanced Elimination of a Persistent Drug Used as a Lipid Absorption Inhibitor by Advanced Oxidation with UV-A and Nanosized Catalysts. Catalysts. 2019; 9(9):761.
https://doi.org/10.3390/catal9090761
Chicago/Turabian Style
Vrinceanu, Narcisa, Raluca Maria Hlihor, Andrei Ionut Simion, Lacramioara Rusu, Ildikó Fekete-Kertész, Noureddine Barka, and Lidia Favier.
2019. "New Evidence of the Enhanced Elimination of a Persistent Drug Used as a Lipid Absorption Inhibitor by Advanced Oxidation with UV-A and Nanosized Catalysts" Catalysts 9, no. 9: 761.
https://doi.org/10.3390/catal9090761
APA Style
Vrinceanu, N., Hlihor, R. M., Simion, A. I., Rusu, L., Fekete-Kertész, I., Barka, N., & Favier, L.
(2019). New Evidence of the Enhanced Elimination of a Persistent Drug Used as a Lipid Absorption Inhibitor by Advanced Oxidation with UV-A and Nanosized Catalysts. Catalysts, 9(9), 761.
https://doi.org/10.3390/catal9090761